**FDA Recalls 600,000 Bottles of Ramipril Medication Due to Contamination Risk**

The FDA has recalled 600,000 bottles of Ramipril, a commonly used blood pressure medication, due to potential contamination from an unregulated manufacturer. The affected capsules, in strengths of 2.5 mg, 5 mg, and 10 mg, were produced by Lupin Pharmaceuticals in India. These medications were sold in bottles of 90, 100, and 150, with sell-by dates up to July 2026.

### Key Details:
– **Affected Strengths:** 2.5 mg, 5 mg, 10 mg
– **Recalled Bottles:** 350,000 (10mg), 146,000 (5mg), 110,000 (2.5mg)
– **Manufacturer:** Lupin Pharmaceuticals
– **Sell-By Dates:** Up to July 2026

Though the recall is classified as a **Class 2** (moderate risk), it’s advised to check your medication and return or dispose of any affected bottles. If you have one of the recalled medications, consult your doctor for a replacement.